April 1, 2025: MDL Against Ozempic and Other GLP-1s Top 1,600 in April As of April 1, 2025, there are 1,685 active lawsuits pending against Novo Nordisk and other pharmaceutical companies that sold GLP-1 drugs like Ozempic
Inositol is a key substrate in glucose metabolism and is a second messenger in insulin action
Waghmare PH, Lindsey R, Reed JB, Gao S, Zillich AJ Systematic review of the impact of medication synchronization on healthcare utilization, economic, clinical, and humanistic outcomes
Is 0.5 mL the same as 50 units
Some people use IV nutrients during heavy travel, high training loads, or recovery windows when food intake is not steady
Enrichment Analysis of the Trx system (A-B) The enrichment circle of GO (A) and KEGG (B) analysis of Trx system genes in LUAD and LUSC